|
METTL14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.02931030155196E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.78723702504158E-12 |
| Normal-vs-Stage2 |
1.827250E-04 |
| Normal-vs-Stage3 |
2.10489999996621E-06 |
| Normal-vs-Stage4 |
2.648700E-04 |
| Stage1-vs-Stage2 |
5.794800E-01 |
| Stage1-vs-Stage3 |
8.794400E-01 |
| Stage1-vs-Stage4 |
4.622200E-01 |
| Stage2-vs-Stage3 |
6.936400E-01 |
| Stage2-vs-Stage4 |
2.475600E-01 |
| Stage3-vs-Stage4 |
3.903600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.85878045867139E-14 |
| Normal-vs-AfricanAmerican |
3.01800029411936E-10 |
| Normal-vs-Asian |
3.312100E-02 |
| Caucasian-vs-AfricanAmerican |
8.921000E-01 |
| Caucasian-vs-Asian |
6.368200E-01 |
| AfricanAmerican-vs-Asian |
6.546600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62747593179802E-12 |
| Normal-vs-Female |
6.63819999968673E-07 |
| Male-vs-Female |
2.301800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.81299999644369E-08 |
| Normal-vs-Extreme_Weight |
1.77724501781995E-12 |
| Normal-vs-Obese |
4.02610000893588E-09 |
| Normal-vs-Extreme_Obese |
1.679360E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.449400E-01 |
| Normal_Weight-vs-Obese |
3.844600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.702400E-01 |
| Extreme_Weight-vs-Obese |
8.080400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.709200E-01 |
| Obese-vs-Extreme_Obese |
3.612000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.013100E-04 |
| Normal-vs-Age(41-60Yrs) |
2.24180007890595E-10 |
| Normal-vs-Age(61-80Yrs) |
7.88258347483861E-15 |
| Normal-vs-Age(81-100Yrs) |
1.789730E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.755800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.829000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.344200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.492500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.865000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.888400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.10382880192628E-15 |
| Normal-VS-Type2 PRCC |
9.6372021474167E-11 |
| Normal-VS-KIRP CIMP |
5.63209999970837E-07 |
| Normal-VS-Unclassified PRCC |
1.004060E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.205200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.177200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.902000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.087600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.813150E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.930000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.6627810239811E-12 |
| Normal-vs-N1 |
4.433400E-04 |
| Normal-vs-N2 |
2.33850000030955E-07 |
| N0-vs-N1 |
5.310300E-02 |
| N0-vs-N2 |
3.027800E-01 |
| N1-vs-N2 |
1.221220E-01 |
|
|
